Körber Secures Landmark Partnership with Leading Chinese Biopharma Giant

Körber has entered into a strategic partnership with Tonghua Anrate Biopharmaceutical Co., Ltd. (Anrate), a leading biopharmaceutical company based in China. Under this agreement, Körber will equip Anrate with an array of advanced manufacturing and digital transformation solutions. These include fully automated pharmaceutical machinery, production software, digital solutions, and comprehensive training and technical support services. These enhancements aim to elevate Anrate's operational excellence in management practices.

By adopting Werum PAS-X MES and Werum PAS-X Savvy, Anrate plans to establish a smart factory that integrates compliance with efficiency. This will enable seamless data interconnection across all stages of pharmaceutical production, expedite Anrate's digital transformation, and foster high-quality, sustainable development within the industry. The signing ceremony was attended by Wei Xiang, Managing Director of Anrate, and Jerry Zheng, Managing Director China of Körber Business Area, along with other key officials.

Wei Xiang commented, "On the occasion of Anrate's tenth anniversary, we are very pleased to have a comprehensive and in-depth cooperation with Körber, whose solutions have unique innovative awareness and industry's best practice experience. We look forward to leveraging the complementary strengths of both parties to provide strong technical support for Anrate's development.”

The signing of this strategic cooperation agreement will allow Anrate to utilize Körber's ongoing technological innovations and solutions in the pharmaceutical sector, thereby boosting the company's smart factory capabilities and manufacturing efficiency.

Jerry Zheng said that, "Technology-assisted is the future direction of pharmaceutical development. Our solutions not only focus on the factory level but also take into account the special requirements of regulatory agencies and the pharmaceutical industry itself. We are firmly convinced that together we can further establish the concept of the ‘Factory of Excellence’ in the pharmaceutical industry and thus create a technological breakthrough that will stand for efficiency and future orientation.”

This strategic agreement signifies a pivotal move for Anrate towards smart manufacturing, paralleled by Körber's significant investment in the Chinese market. Together, Körber and Anrate aim to pioneer intelligence, efficiency, and sustainable practices in the biopharmaceutical industry, setting a new standard for smart manufacturing in China's pharmaceutical sector.